Willie Martin, Director, Discovery Process, Alkermes | Pharma Tech Outlook

Applications of AI in Drug Discovery

Willie Martin, Director, Discovery Process, Alkermes
Cynthia A. Challener, Ph.D., Scientific Content Director, That’s Nice LLC  | Pharma Tech Outlook

Increasing Clinical Trial Efficiency with Cloud-Based EDC Solutions

Cynthia A. Challener, Ph.D., Scientific Content Director, That’s Nice LLC
Narayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor [NYSE:AVTR] | Pharma Tech Outlook

Cell and Gene Therapy-Navigating the Next Frontier in Biomanufacturing

Narayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor [NYSE:AVTR]
Jim Kremidas, Executive director, Association of Clinical Research Professionals | Pharma Tech Outlook

Present-Day Clinical Trial Landscape

Jim Kremidas, Executive director, Association of Clinical Research Professionals
Lawrence Fernandes, Director, Asia Pacific Human Health IT, MSD | Pharma Tech Outlook

The Role of IT Leaders, Reimagined for Pharma in Asia

Lawrence Fernandes, Director, Asia Pacific Human Health IT, MSD
Safwan Kezbor, M.D., Executive Medical Director, Global Clinical Development, Shionogi | Pharma Tech Outlook

A Glimpse into the Future of Rare Diseases Drug Development: The Latest Advances and Innovations

Safwan Kezbor, M.D., Executive Medical Director, Global Clinical Development, Shionogi
Rishi Kakar, Chief Scientific Officer and Medical Director, Segal Trials | Pharma Tech Outlook

Advancing Clinical Research Through Scientific Rigor and Innovation

Rishi Kakar, Chief Scientific Officer and Medical Director, Segal Trials
Cori L. Rizman, Vice President of DEA Compliance, Ascent Pharmaceuticals, Inc | Pharma Tech Outlook

Inside DEA Compliance: Risk, Pressure, and Leadership

Cori L. Rizman, Vice President of DEA Compliance, Ascent Pharmaceuticals, Inc
Jennifer Vavala, Executive Director, Quality and Compliance, PCI Pharma Services | Pharma Tech Outlook

Navigating Regulatory Complexity in Pharma Operations

Jennifer Vavala, Executive Director, Quality and Compliance, PCI Pharma Services